hiw3c 日报精选
arXiv cs.AI/CL/LG 网页快照

分子相互作用基础模型中的新兴生物能力

原文标题 · Emergent Biological Capabilities in a Foundation Model for Molecular Interactions

作者: Adi Mashiach | 在大型未标记语料库上训练的基础模型能够产生新兴能力,即超出训练目标的任务。我们将这一范式拓展至多模态生物学领域,引入Bonbon,这是一个针对分子相互作用的基础模型,在约3.2万亿个配对蛋白-配体序列标记语元上进行训练。从单一表示空间来看,Bonbon展现出三种零样本新兴能力

来源:arXiv cs.AI/CL/LG · arxiv.org

正文为英文,可一键机器翻译(仅首次需要等待)

Computer Science > Machine Learning

Title: Emergent Biological Capabilities in a Foundation Model for Molecular Interactions

Abstract: Foundation models trained on large unlabeled corpora develop emergent capabilities, tasks that go beyond the training objective. We extend this paradigm to multimodal biology with Bonbon, a foundation model for molecular interactions trained on approximately 3.2 trillion tokens of paired protein-ligand sequences. From a single representation space, Bonbon exhibits three zero-shot emergent capabilities at hierarchical levels of resolution: functional (mechanism of action), residue (binding site localization, including orthosteric/allosteric discrimination), and bond (covalent versus non-covalent engagement). All three capabilities generalize to out-of-distribution complexes. Bonbon was trained on protein-ligand sequences alone, without any task-specific supervision and without structural coordinates. We conducted controlled scaling experiments across six model scales from 42M to 1.6B parameters; every capability evaluated shows a sharp jump at the largest scale on continuous metrics, even as pretraining loss decreases smoothly. This demonstrates that loss-based scaling laws alone are insufficient to predict when zero-shot emergent capabilities become available. The capabilities reported here emerge after training at a 1:2,000 parameter-to-token ratio to accommodate the sparsity of paired biological interaction data. The same frozen representations achieve state-of-the-art binding and affinity prediction at five orders of magnitude greater speed than co-folding methods. In prospective wet-lab validation across nine disease targets spanning seven protein families, Bonbon achieves a 61.5% dose-response hit rate on de novo compounds, yielding structurally novel molecules not previously reported to inhibit these proteins, including for out-of-distribution targets.

Submission history

Access Paper:

Additional Features

Current browse context:

References & Citations

BibTeX formatted citation

Bookmark

Bibliographic and Citation Tools

Code, Data and Media Associated with this Article

Demos

Recommenders and Search Tools

arXivLabs: experimental projects with community collaborators

arXivLabs is a framework that allows collaborators to develop and share new arXiv features directly on our website.

Both individuals and organizations that work with arXivLabs have embraced and accepted our values of openness, community, excellence, and user data privacy. arXiv is committed to these values and only works with partners that adhere to them.

Have an idea for a project that will add value for arXiv's community? Learn more about arXivLabs .